Source: DistilINFO — 2026-06-29 (event held 2026-06-25)
Summary
Senior HHS leadership held a cross-agency "One HHS" briefing on findings from a December 2025 Request for Information on clinical AI adoption, which drew more than 7,000 public comments, signaling a federal policy push toward AI agents that diagnose and adjust medications with reduced physician mediation — not just documentation assistance.
Key Takeaways
- The underlying RFI drew more than 7,000 public comments, an unusually large response for a clinical-AI policy question.
- HHS is organizing the initiative under a "One HHS" cross-agency banner, building on its late-2025 federal AI strategy.
- Officials explicitly discussed autonomous agents that diagnose and adjust medications, a step beyond the ambient-documentation tools already in wide clinical use.
- Liability and accountability for autonomous agent errors was raised at the briefing as an unresolved open question.